Evolocumab has no effects on heart failure with reduced ejection fraction injury biomarkers: The EVO-HF trial.
Bayes-Genis A, Lupón J, Revuelta-Lopez E, Llibre C, Gastelurrutia P, Domingo M, Cediel G, Codina P, Santiago-Vacas E, Rangel-Sousa D, Fernández-Cisnal A, Miñana G, Mollar A, Núñez J.
Bayes-Genis A, et al. Among authors: mollar a.
Eur J Heart Fail. 2023 Aug;25(8):1439-1443. doi: 10.1002/ejhf.2932. Epub 2023 Jun 27.
Eur J Heart Fail. 2023.
PMID: 37323111